GlycoMimetics (GLYC) Short Interest Ratio & Short Volume $0.27 0.00 (0.00%) (As of 07/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GlycoMimetics Short Interest DataCurrent Short Interest1,760,000 sharesPrevious Short Interest2,090,000 sharesChange Vs. Previous Month-15.79%Dollar Volume Sold Short$462,880.00Short Interest Ratio0.4 Days to CoverLast Record DateJune 15, 2024Outstanding Shares64,464,000 sharesPercentage of Shares Shorted2.73%Today's Trading Volume1,457,269 sharesAverage Trading Volume8,826,433 sharesToday's Volume Vs. Average17% Short Selling GlycoMimetics ? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time Ad Behind the Markets[BUY ALERT] “This Could Be Worth 28X More than NVIDIA”This firm's stock is currently trading for only $15. But that won't last long. Because even OpenAI founder Sam Altman admits AI "depends" on this firm's work.Click here for the ticker >>> GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20241,760,000 shares $462,880.00 -15.8%N/A0.4 $0.26 5/31/20242,090,000 shares $566,390.00 -10.7%N/A1.2 $0.27 5/15/20242,340,000 shares $631,800.00 -61.6%N/A1.5 $0.27 4/30/20246,090,000 shares $10.96 million +102.3%N/A4.6 $1.80 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389,412.03 +19.7%1.4%5.1 $0.68Obama’s DNC coup (Ad)As we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In fact, according to Tucker Carlson, in private even "Obama is telling people Biden can't win, and he is therefore in favor of an open convention."WHO will they replace Biden with? 10/15/2022479,700 shares $298,133.55 +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258,581.79 -5.8%1.1%3.6 $0.55 9/15/2022497,300 shares $341,098.07 -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384,788.00 +6.1%1.2%3.5 $0.76 8/15/2022477,300 shares $400,932.00 -10.9%1.1%3.5 $0.84 7/31/2022535,500 shares $355,036.50 -6.8%1.6%3.6 $0.66 7/15/2022574,500 shares $363,141.45 +4.3%1.7%3.4 $0.63 6/30/2022551,000 shares $329,442.90 -17.1%1.7%3.1 $0.60 6/15/2022664,400 shares $372,794.84 +2.3%2.0%3.7 $0.56 5/31/2022649,500 shares $432,437.10 +5.8%1.5%3.7 $0.67 5/15/2022613,700 shares $346,126.80 -2.3%1.5%3.1 $0.56 4/30/2022628,300 shares $451,496.38 +3.9%1.5%3 $0.72 4/15/2022605,000 shares $605,000.00 -1.1%1.4%3 $1.00 3/31/2022612,000 shares $697,680.00 -2.3%1.5%2.9 $1.14 3/15/2022626,400 shares $645,192.00 -8.9%1.5%2.6 $1.03 2/28/2022687,600 shares $845,748.00 +1.3%1.7%2.6 $1.23 2/15/2022678,600 shares $719,316.00 -10.1%1.6%2.4 $1.06 1/31/2022754,700 shares $898,093.00 +13.5%1.8%2.4 $1.19 1/15/2022665,200 shares $824,848.00 +1.2%N/A2 $1.24 12/31/2021657,600 shares $946,944.00 -2.7%1.6%1.9 $1.44 12/15/2021676,000 shares $1.03 million +1.8%1.6%1.1 $1.52 11/30/2021664,300 shares $1.12 million -10.2%1.6%1 $1.69 11/15/2021739,400 shares $1.58 million -0.5%1.8%1.1 $2.14 10/29/2021743,300 shares $1.42 million -12.7%1.8%1.2 $1.91 10/15/2021851,000 shares $1.68 million -21.9%2.1%1.3 $1.98 9/30/20211,090,000 shares $2.39 million +1.9%2.6%1.7 $2.19 9/15/20211,070,000 shares $2.29 million -2.7%2.6%2.1 $2.14 8/31/20211,100,000 shares $2.44 million -28.6%2.7%2.4 $2.22 8/13/20211,540,000 shares $3.05 million -6.7%3.7%3.2 $1.98 7/30/20211,650,000 shares $3.33 million No Change4.0%2.4 $2.02 7/15/20211,650,000 shares $3.35 million +7.1%4.0%2.3 $2.03 6/30/20211,540,000 shares $3.57 million -37.1%3.7%1.9 $2.32 6/15/20212,450,000 shares $6.32 million -11.6%5.9%3.2 $2.58 5/28/20212,770,000 shares $7.06 million +26.5%6.7%3.5 $2.55 5/14/20212,190,000 shares $5.52 million -11.0%5.3%2.4 $2.52 4/30/20212,460,000 shares $6.15 million +74.5%6.0%3 $2.50 4/15/20211,410,000 shares $3.71 million +6.8%3.4%1.6 $2.63 3/31/20211,320,000 shares $3.83 million +3.9%3.2%1.5 $2.90 3/15/20211,270,000 shares $4.20 million +18.7%3.2%1.5 $3.31 2/26/20211,070,000 shares $3.66 million +16.4%2.7%1.3 $3.42 2/12/2021919,100 shares $3.74 million +4.6%2.5%1.2 $4.07 1/29/2021878,800 shares $3.22 million -2.9%2.3%1.2 $3.66 1/15/2021904,700 shares $3.40 million -54.3%2.4%1.3 $3.76 12/31/20201,980,000 shares $7.50 million -21.7%5.3%3.2 $3.79 12/15/20202,530,000 shares $9.21 million +36.0%6.7%4.3 $3.64 11/30/20201,860,000 shares $6.81 million -5.6%4.9%3.7 $3.66 11/15/20201,970,000 shares $6.88 million +1.0%5.2%4.7 $3.49 10/30/20201,950,000 shares $5.62 million -11.4%5.2%5.6 $2.88 10/15/20202,200,000 shares $7.55 million +8.9%5.8%7.4 $3.43 9/30/20202,020,000 shares $6.20 million -5.6%5.4%5.2 $3.07Biden to drop out; finish out his term? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. 9/15/20202,140,000 shares $7.62 million -0.5%5.7%4.2 $3.56 8/31/20202,150,000 shares $7.93 million -2.7%5.7%2.8 $3.69 8/14/20202,210,000 shares $8.18 million -3.5%6.0%2.8 $3.70 7/31/20202,290,000 shares $9.02 million -7.7%6.2%2.9 $3.94 7/15/20202,480,000 shares $9.94 million -11.1%7.4%3.3 $4.01 6/30/20202,790,000 shares $10.49 million +4.5%8.3%4.1 $3.76 6/15/20202,670,000 shares $8.09 million -0.4%8.0%4.8 $3.03 5/29/20202,680,000 shares $7.58 million -0.7%8.0%8 $2.83 5/15/20202,700,000 shares $8.40 million -3.2%8.1%8.5 $3.11 4/30/20202,790,000 shares $7.78 million -3.1%8.3%9.9 $2.79 4/15/20202,880,000 shares $7.43 million -6.8%8.6%11.2 $2.58 3/31/20203,090,000 shares $7.73 million -4.6%9.2%12.1 $2.50 3/13/20203,240,300 shares $8.62 million +0.9%9.7%15.9 $2.66 2/28/20203,210,000 shares $6.90 million +0.6%9.6%15.4 $2.15 2/14/20203,190,000 shares $9.89 million -4.8%9.6%14.4 $3.10 1/31/20203,350,000 shares $12.26 million +3.1%10.1%13.9 $3.66 1/15/20203,250,000 shares $14.17 million -1.5%9.8%13.1 $4.36 12/31/20193,300,000 shares $15.05 million +0.9%9.9%13.3 $4.56 GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 1,760,000 shares of GLYC short. Learn More on GlycoMimetics' current short interest. Which institutional investors are shorting GlycoMimetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: Ikarian Capital LLC, Affinity Asset Advisors LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 1,760,000 shares, a decrease of 15.8% from the previous total of 2,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to GlycoMimetics: Anixa Biosciences, Inc. (1.86%), MediciNova, Inc. (0.24%), Milestone Pharmaceuticals Inc. (0.80%), Spero Therapeutics, Inc. (0.80%), SELLAS Life Sciences Group, Inc. (13.07%), Anebulo Pharmaceuticals, Inc. (0.12%), Genelux Co. (6.22%), Eledon Pharmaceuticals, Inc. (0.21%), Benitec Biopharma Inc. (0.43%), Theratechnologies Inc. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is June, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Anixa Biosciences Short Interest MediciNova Short Interest Milestone Pharmaceuticals Short Interest Spero Therapeutics Short Interest SELLAS Life Sciences Group Short Interest Anebulo Pharmaceuticals Short Interest Genelux Short Interest Eledon Pharmaceuticals Short Interest Benitec Biopharma Short Interest Theratechnologies Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 7/5/2024 by MarketBeat.com Staff From Our PartnersBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.